The Manufacturers Life Insurance Company Sells 25,163 Shares of Teleflex Incorporated (NYSE:TFX)

The Manufacturers Life Insurance Company reduced its stake in Teleflex Incorporated (NYSE:TFXFree Report) by 14.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,421 shares of the medical technology company’s stock after selling 25,163 shares during the quarter. The Manufacturers Life Insurance Company owned 0.32% of Teleflex worth $38,005,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lindbrook Capital LLC grew its stake in shares of Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 58 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its holdings in Teleflex by 418.5% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after acquiring an additional 113 shares in the last quarter. Covestor Ltd boosted its position in Teleflex by 305.6% during the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 110 shares during the last quarter. Janiczek Wealth Management LLC boosted its holdings in shares of Teleflex by 227.1% in the 4th quarter. Janiczek Wealth Management LLC now owns 157 shares of the medical technology company’s stock valued at $39,000 after buying an additional 109 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in Teleflex by 33.3% in the 4th quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company’s stock valued at $46,000 after purchasing an additional 46 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. Truist Financial reduced their price target on Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a research report on Friday, May 3rd. Finally, Royal Bank of Canada dropped their price objective on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $257.29.

Read Our Latest Stock Analysis on Teleflex

Teleflex Stock Performance

Shares of Teleflex stock opened at $216.40 on Friday. The business’s fifty day simple moving average is $210.98 and its 200 day simple moving average is $228.24. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $10.19 billion, a P/E ratio of 34.74, a price-to-earnings-growth ratio of 2.09 and a beta of 1.16. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $262.97.

Teleflex (NYSE:TFXGet Free Report) last issued its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, topping analysts’ consensus estimates of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same quarter last year, the business earned $3.09 earnings per share. The company’s quarterly revenue was up 3.8% on a year-over-year basis. As a group, analysts anticipate that Teleflex Incorporated will post 13.75 EPS for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.36 annualized dividend and a dividend yield of 0.63%. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Teleflex Company Profile

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.